Screener
Gyre Therapeutics, Inc. GYRE Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
| Line item | Three Months Ended June 30, | Six Months Ended June 30, |
|---|---|---|
| (Loss) income from operations | (2,240)) | 302) |
| Other (loss) income, net: | ||
| Interest income | 941 | 1,797 |
| Other expense, net | (488)) | (301)) |
| Change in fair value of warrant liability | 212 | 2,467 |
| (Loss) Income before income taxes | (1,575)) | 4,265) |
| Benefit (provision) for income taxes | (662) | (1,563)) |
| Net (loss) income | (2,237)) | 2,702) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Gyre Therapeutics, Inc.'s other income (expense)?
- Gyre Therapeutics, Inc. (GYRE) reported other income (expense) of -$943K in Q2 2026.
- How has Gyre Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Gyre Therapeutics, Inc.'s other income (expense) decreased by 93.2% year-over-year, from -$488K to -$943K.
- What is the long-term trend for Gyre Therapeutics, Inc.'s other income (expense)?
- Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s other income (expense) has grown at a 10.3% compound annual growth rate (CAGR), from -$1.52M to -$1.85M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Gyre Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude